SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001279569-12-001012
Filing Date
2012-08-10
Accepted
2012-08-10 14:10:35
Documents
11
Period of Report
2012-08-10

Document Format Files

Seq Description Document Type Size
1 FORM 6-K v320943_6k.htm 6-K 11941
2 EXHIBIT 99.1 v320943_ex99-1.htm EX-99.1 539115
3 EXHIBIT 99.2 v320943_ex99-2.htm EX-99.2 399979
4 EXHIBIT 99.3 v320943_ex99-3.htm EX-99.3 314407
5 EXHIBIT 99.4 v320943_ex99-4.htm EX-99.4 28002
6 GRAPHIC ex99-1pg2.jpg GRAPHIC 5527
7 GRAPHIC ex99-1pg3a.jpg GRAPHIC 2163
8 GRAPHIC ex99-1pg3b.jpg GRAPHIC 7423
9 GRAPHIC ex99-2logo.jpg GRAPHIC 20207
10 GRAPHIC ex99-3logo.jpg GRAPHIC 23335
11 GRAPHIC ex99-3pg6.jpg GRAPHIC 133140
  Complete submission text file 0001279569-12-001012.txt   1559777
Mailing Address 2 MERIDIAN ROAD TORONTO A6 M9W 4Z7
Business Address 2 MERIDIAN ROAD . TORONTO A6 M9W 4Z7
LORUS THERAPEUTICS INC (Filer) CIK: 0000882361 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 0531
Type: 6-K | Act: 34 | File No.: 001-32001 | Film No.: 121024025
SIC: 2836 Biological Products, (No Diagnostic Substances)